Agomelatine: A Versatile Pharmaceutical Intermediate for CNS Research
The development of effective treatments for Central Nervous System (CNS) disorders requires access to high-quality, well-characterized pharmaceutical intermediates. Agomelatine, identified by CAS number 6836-19-7, is one such compound that has emerged as a valuable tool for CNS research due to its unique pharmacological properties.
NINGBO INNO PHARMCHEM CO.,LTD. provides researchers with superior Agomelatine, a white powder that serves as a key intermediate in the synthesis of drugs targeting neurological and psychiatric conditions. Agomelatine's dual mechanism of action – acting as a melatoninergic agonist and a selective 5-HT2C receptor antagonist – makes it particularly interesting for studies aimed at understanding and treating disorders like depression, anxiety, and sleep disturbances. Its ability to influence both circadian rhythms and neurotransmitter systems offers a multifaceted approach to therapeutic intervention.
Our commitment to quality is unwavering. As a GMP certified Agomelatine manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. adheres to the highest industry standards throughout the production process. This ensures that our Agomelatine intermediate possesses the exceptional purity and consistency necessary for critical CNS research applications. We understand that the success of complex research projects often hinges on the reliability of the starting materials, making our product a trusted choice for scientists worldwide.
For organizations looking to buy Agomelatine for their R&D efforts, NINGBO INNO PHARMCHEM CO.,LTD. offers competitive pricing and reliable supply chains. We aim to be more than just a supplier; we strive to be a partner in scientific advancement. Whether you are exploring new drug targets, optimizing synthesis pathways, or conducting in-depth pharmacological studies, our high-purity Agomelatine is an indispensable resource. We encourage you to inquire about our Agomelatine for sale and discover how our commitment to quality can support your next breakthrough in CNS research.
Perspectives & Insights
Bio Analyst 88
“The development of effective treatments for Central Nervous System (CNS) disorders requires access to high-quality, well-characterized pharmaceutical intermediates.”
Nano Seeker Pro
“Agomelatine, identified by CAS number 6836-19-7, is one such compound that has emerged as a valuable tool for CNS research due to its unique pharmacological properties.”
Data Reader 7
“provides researchers with superior Agomelatine, a white powder that serves as a key intermediate in the synthesis of drugs targeting neurological and psychiatric conditions.”